Japanese Patent JPH0322874

B2

1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE The L-arginine salt of N-(D)-{[2-(2,6-dichlorophenylamino)phenyl]acetyl}aspartic acid, represented by the formula see diagramm : EP0253293,P9,F3 in which AmH (anion) represents the cation derived from L-arginine Am of the formula see diagramm : EP0253293,P10,F1 and its hydrates. 1. Claims for the Contracting States : AT, ES, GR A process for the manufacture of the L-arginine salt of N-(D)-{[2-(2,6-dichlorophenylamino)phenyl]acetyl}aspartic acid, represented by the formula see diagramm : EP0253293,P11,F1 in which AmH (anion) represents the cation derived from L-arginine Am of the formula see diagramm : EP0253293,P11,F2 and its hydrates, characterised in that L-arginine is reacted with N-(D)-{[2-(2,6-dichlorophenylamino)phenyl]acetyl}aspartic acid L-arginine salt in the form of the trihydrate is measured.

JPH02264751	PHARMACEUTICALLY ACTIVE COMPOUND
WO/2023/022899	POTASSIUM HYDROGEN SALTS OF ALKYLHYDROXAMATES AND COMPOSITIONS COMPRISING THE SAME
JP4652664	Treatment of lung disease with gaseous drugs that cause GSNO sufficiency

GERUHARUTO BASHANKU
ARUFURETSUTO ZARUMAN

JP17129987A

March 27, 1991

July 10, 1987

Click for automatic bibliography generation  

CIBA GEIGY

A61K31/16; A61K31/195; A61K31/198; A61K31/205; A61P25/04; A61P29/00; C07C67/00; C07C231/12; C07C233/12; C07C233/47; C07C237/20; C07C237/36; C07C239/00; C07C279/14; C07K5/02

Next Patent: JPH0322875